Wikisage, the free encyclopedia of the second generation, is digital heritage
Turmeric: Difference between revisions
Jump to navigation
Jump to search
m (→Links) |
m (→Links) |
||
Line 6: | Line 6: | ||
Turmeric turn to be ''interessant'' for neuplasies and glucaemia treatment | Turmeric turn to be ''interessant'' for neuplasies and glucaemia treatment | ||
==Links== | ==Links== | ||
<ref>http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=200028370</ref> | |||
[http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078737 Biological Diversity in the Patent System] | [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078737 Biological Diversity in the Patent System] | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774370/pdf/etm-11-03-0998.pdf Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774370/pdf/etm-11-03-0998.pdf Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways] |
Revision as of 18:58, 25 April 2016
Turmeric turn to be interessant for neuplasies and glucaemia treatment
Links
Biological Diversity in the Patent System
Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.